Asif Ali, Chief Financial Officer of Protagonist Therapeutics, Inc. (PTGX), executed a significant sale of company shares on October 2, 2026. Ali sold 46,034 shares at a price of $141.78 each, resulting in a transaction valued at approximately $6.53 million.
This transaction follows a series of other insider sales at Protagonist Therapeutics. Earlier in September, Dinesh V. Patel, Ph.D., sold a cumulative total of 190,500 shares across multiple transactions, amounting to over $26 million.
Insider sales can be influenced by various personal financial strategies, such as portfolio diversification or meeting tax obligations, and do not necessarily indicate a negative view of the company's prospects.